Korea United Pharm Inc. (033270.KS)

KRW 18480.0

(-1.75%)

Annual Cash Flows

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow 50.64 Billion 63.78 Billion 44.08 Billion 36.96 Billion 38.15 Billion 36.86 Billion
Net Income 48.26 Billion 45.27 Billion 28.64 Billion 26.61 Billion 30.91 Billion 31.67 Billion
Depreciation & Amortization 10.09 Billion 8.98 Billion 7.67 Billion 8.49 Billion 7.26 Billion 7.33 Billion
Deferred income taxes -30.98 Billion - 1.12 Billion 4.12 Billion -2.29 Billion -
Stock-based compensation 288.18 Million 341.52 Million 327.39 Million 240.74 Million 150.66 Million 58.34 Million
Change in working capital -10.3 Billion 4.33 Billion 6.69 Billion -1.43 Billion 4.5 Billion -1.53 Billion
Other non-cash items 33.29 Billion 4.83 Billion -376.2 Million -1.08 Billion -2.39 Billion -669.06 Million
Investing Cash Flow -56.41 Billion -87.9 Billion -17.69 Billion -33.72 Billion -19.97 Billion -21.79 Billion
Investments in PPE -31.3 Billion -24.2 Billion -12.78 Billion -12.54 Billion -19.75 Billion -17.34 Billion
Acquisitions 12.19 Million 618.92 Million -88.86 Million -1.92 Billion -361.74 Million 111.58 Million
Investment purchases -266.8 Billion -293.31 Billion -63.44 Billion -63.06 Billion -37.96 Billion -37.55 Billion
Sales/Maturities of investments 241.3 Billion 228.07 Billion 56.57 Billion 43.46 Billion 37.21 Billion 33.52 Billion
Other Investing Activities 389.49 Million 927.49 Million 2.04 Billion 347.85 Million 898.76 Million -532.61 Million
Financing Cash Flow 2.54 Billion -10.58 Billion -8.19 Billion -1.78 Billion -1.72 Billion -546.04 Million
Debt repayment -10.1 Billion -18.94 Billion -19.28 Billion -4.16 Billion -11.21 Billion -15.08 Billion
Dividends payments -5.88 Billion -5.49 Billion -5.19 Billion -4.89 Billion -4.88 Billion -4.44 Billion
Common Stock Repurchased -1.95 Billion -3.04 Billion - 7.06 Billion 14 Billion -
Common Stock Issuance -88.05 Million - - 242.38 Million 431.89 Million -
Other Financing Activities 20.57 Billion 16.89 Billion 16.28 Billion -30.46 Million -47.56 Million 18.97 Billion
Accounts receivables -2.18 Billion -2.81 Billion 2.67 Billion 6.43 Billion 2.73 Billion -434.37 Million
Accounts payables -257.79 Million 2.05 Billion 464.86 Million -921.4 Million 220.59 Million 319.33 Million
Inventory -8.06 Billion 2.71 Billion 2.62 Billion -6.3 Billion -1.7 Billion -5.17 Billion
Other working capital 206.79 Million 2.38 Billion 931.17 Million -640.96 Million 3.24 Billion 3.63 Billion
Cash at beginning of period 26.89 Billion 60.82 Billion 40.48 Billion 40 Billion 24.3 Billion 10 Billion
Cash at end of period 23.91 Billion 26.89 Billion 60.82 Billion 40.48 Billion 40 Billion 24.3 Billion
Capital Expenditure -31.3 Billion -24.2 Billion -12.78 Billion -12.54 Billion -19.75 Billion -17.34 Billion
Effect of forex changes on cash 233.91 Million 773.05 Million 2.15 Billion -976.33 Million -767.99 Million -219.93 Million
Net cash flow / Change in cash -2.98 Billion -33.93 Billion 20.34 Billion 476.65 Million 15.69 Billion 14.3 Billion
Free Cash Flow 19.33 Billion 39.57 Billion 31.29 Billion 24.41 Billion 18.39 Billion 19.51 Billion

Cash Flow Charts